NeurologyLive® Friday 5 — April 21, 2023

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Managing Nonmotor Symptoms: Psychosis in Parkinson Disease

Featured in our print April edition, psychosis is estimated to affect more than half of patients with Parkinson disease, and there is a growing need for improved management and therapeutic development.

2: Peer Exchange: Narcolepsy Overview

In episode 2 of this Peer Exchange series on "Advances in the Management of Excessive Daytime Sleepiness and Narcolepsy", experts in neurology provide an overview of excessive daytime sleepiness and narcolepsy.

3: NeuroVoices: Aaron Ritter, MD, on Navigating Treatment Options for Parkinson Disease Psychosis

In the latest edition of our in-depth Q&A series, director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute, provided perspective on the recently launched program for Parkinson disease.

4: Cure Connection: Treatment Adherence and Comprehensive Care in Multiple Sclerosis

In episode 2 of this Cure Connection series, "The Patient Journey in the Management of Multiple Sclerosis," experts highlight the role of comprehensive care and importance of treatment adherence for people living with multiple sclerosis.

5: Analyzing Specific Pathways in Cells to Prevent Relapse in NMOSD: Shuhei Nishiyama, MD, PhD

The research fellow at the Neuroimmunology Clinic and Research Laboratory, Massachusetts General Hospital and Harvard Medical School shared what he is excited about regarding presenting his data at the 2023 American Academy of Neurology (AAN) Annual Meeting, April 22-27, in Boston, Massachusetts.